320 likes | 785 Views
Nociception and Pain. Definition of Pain (IASP) “An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.”. Nociception vs Pain. Tranduction* Conduction Spinal Processing Perception.
E N D
Nociception and Pain Definition of Pain (IASP) “An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.”
Nociception vs Pain • Tranduction* • Conduction • Spinal Processing • Perception *Nociceptors are a specific subset of peripheral sensory organs which respond to noxious stimuli.
Categories of Pain Physiological Clinical Persistent
Physiological Pain • “Fast” pain – carried by Ad fibers • Sharp • Well-localized • “Slow” pain – carried by C fibers • Aching • Poorly localized
Nociceptor Activation Heat VR1 nucleus Ca+2 Glutamate ATP P2X2 H+ ASIC Na+/Ca+2 ? PKA/PKC Bradykinin Mechanical VR1= vanilloid receptor ASIC=acid sensing ion channels P2X2=purinergic receptor
Nociceptors in Teeth • 1. A fibers • thermoreceptors • mechanoreceptor • 2. C fibers • polymodal (chemoreceptors)
Hydrodynamic Mechanism of Dental Pain • Odontoblast • Predentin • Dentin • Odontoblastic Process • Subodontoblastic Nerve Plexus • A Fiber • Axon Terminal in Tubule
Spinal Processing • Nociceptive nerve endings synapse in the spinal cord (substantia gelatinosa) or medulla (nucleus of the spinal tract of CN V). • Information passed to thalamus through the activation of secondary (projection) neurons. Spinal Nucleus (C.N. V) Substantia Gelatinosa
Referred Pain Visceral Nociceptors • Fibers usually run with autonomic fibers • Large receptive fields • Converge on neurons that receive somatic input
AMPA Receptor (a-Amino-3-hydroxy-5-methylisoxazole-4-proprionic acid) • Natural agonist is glutamate • Permeable to Na+ and K+, but not Ca2+ • Channel opening short (10 ms) SP C Glu PN Na+ Glu K+ Ad
Ascending CNS Pathways • Spino- and trigemino-thalamic tracts • Thalamus (sensory-discrimination) • Reticular/limbic systems (motivational-affective) • Cortex (cognitive-evaluative)
Gate Control Theory of Pain (Melzack and Wall, 1965) Ad & C Ab
Descending CNS Pathways Inhibition Facilitation
Inhibition Facilitation 5-HT, NA(a2) GABA, GLY ENK, DNY bEN, ACh 5-HT, NA(a1) GLUT, SP ACh (nic) PAIN + EXIN ININ + + ACh(nic) CCK DNY (N) bEN, GABA GLY, ENK DNY (k) DRG DRG SP GLUT SP GLUT - - + + Nx + Nx + PN PN
Endogenous Opioids & Stress-induced Analgesia • Enkephalins – dorsal horn • Dynorphins – hypothalamus, PAG, dorsal horn • -endorphins (involved in stress-induced analgesia) – hypothalamus
Clinical Pain (Inflammatory or Post-surgical Pain) Pain Response “Pain Threshold” Stimulus Intensity An increased response to a normally painful stimulus An painful response to a normally innocuous stimulus Hyperalgesia Allodynia
Primary Hyperalgesia “Peripheral Sensitization” Na+ Channels TTx-S/TTx-R B: Transcription B VR1, Na+ channels. Heat VR1 Glutamate SP H+ ASIC A ATP P2X2 PG’s Bradykinin NGF Cytokines A: Sensitization
Secondary Hyperalgesia “Central Sensitization” Periphery CNS Injury site DRG/TG • Injury and inflammatory response results in increased nociceptor activation • Afferent barrage leads to: • Increased excitability • Decreased inhibition
Glu SP Mg++ AMPA NMDA Ca++ IP3 PN NMDA Receptor (N-methyl-D-aspartate) • Natural agonist is glutamate; usually blocked by Mg2+ • Depolarization opens channel by removing block • Channel opening has a long duration (100 ms) permitting summation of inputs (“wind-up”)
Na+ Channels TTx-S/TTx-R VR1 Glutamate SP ASIC P2X2 PG’s Opioids Cytokines The Pharmacological Approach
Inhibition Facilitation 5-HT, NA(a2) GABA, GLY ENK, DNY bEN, ACh 5-HT, NA(a1) GLUT, SP ACh (nic) PAIN + EXIN ININ + + ACh(nic) CCK DNY (N) bEN, GABA GLY, ENK DNY (k) DRG DRG SP GLUT SP GLUT - - + + Nx + Nx + PN PN
The Problem of Persistent Pain • Peripheral Processes • Spontaneous activity • Sympathetic activity • Nociceptor sensitization • Central Processes • Central sensitization • Spinal reorganization • Cortical reorganization • Loss of inhibitory pathways